0001064901-23-000001.txt : 20230601 0001064901-23-000001.hdr.sgml : 20230601 20230601143837 ACCESSION NUMBER: 0001064901-23-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230530 FILED AS OF DATE: 20230601 DATE AS OF CHANGE: 20230601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY CHRISTINA CENTRAL INDEX KEY: 0001064901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 23984252 MAIL ADDRESS: STREET 1: C/O 225 LONG AVENUE CITY: HILLSIDE STATE: NJ ZIP: 07205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222407475 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 225 LONG AVENUE STREET 2: BUILDING 15 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-05-30 0 0001016504 INTEGRATED BIOPHARMA INC INBP 0001064901 KAY CHRISTINA C/O 225 LONG AVENUE HILLSIDE NJ 07205 1 1 0 0 Co-Chief Executive Officer 0 Common Stock 2023-05-30 4 G 0 50000 0.34 A 1811800 D Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death. Closing price of Common Stock on date of gift, May 30, 2023. /s/ Christina Kay 2023-06-01